Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

End-stage valvular heart disease requiring heart transplantation: risk profile, surgical modifiers, and myocardial pathology.

BMC cardiovascular disorders - 28 Apr 2026

Wang Yifan, Zhao Yiqi, Wang Weiteng, Jia Hao, Chen Xiao, Mo Han, Sun Zhe, Wang Xiaohu, Shu Songren, Shi Hongjie, Luo Zhiling, Hua Xiumeng, Cui Hao, Song Jiangping

Abstract excerpt

BACKGROUND: End-stage valvular heart disease (VHD) constitutes a small but high-risk subset of heart transplant (HTx) recipients, and data describing their natural history and determinants of progression to HTx are limited. We aimed to characterize the clinical, genetic, surgical, and pathological substrates of patients undergoing HTx for end-stage VHD and to assess whether timely cardiac valvular surgery (CVS)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Transplantation

Share to Heart Valve Diseases

Share to Heart Valve Prosthesis Implantation

Share to Myocardium

Share to Risk Assessment

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 42050441
DOI: 10.1186/s12872-026-05814-9
PMCID: PMC13267388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

End-stage valvular heart disease requiring heart transplantation: risk profile, surgical modifiers, and myocardial pathology.PMID 42050441Read ↗

Survival by Heart Failure Phenotype in a Fontan Surveillance Population, 2010-2023Semantic proximity Read ↗

Phenotypic Diversity and Outcomes of Transcatheter Mitral Repair for Secondary Mitral Regurgitation: Insights From the COAPT and MITRA-FR Trials.Semantic proximity Read ↗

Heart failure treatment in adults with congenital heart disease: where do we stand in 2014?Semantic proximity Read ↗

Clinical Characteristics, Outcomes and Regional Variations of Acquired Valvular Heart Disease Patients Undergoing Cardiac Surgery Between 2016 and 2018 in ChinaSemantic proximity Read ↗

Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure.Semantic proximity Read ↗

Genetic architecture of heart failure with preserved versus reduced ejection fractionSemantic proximity Read ↗

Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences.Semantic proximity Read ↗

Atrial Secondary Mitral Regurgitation: Pathophysiology, Diagnosis, and Surgical ImplicationsSemantic proximity Read ↗

The natural history of acute dilated cardiomyopathy.Semantic proximity Read ↗

Cellular Landscapes of Nondiseased Human Cardiac Valves From End-Stage Heart Failure–Explanted HeartSemantic proximity Read ↗

The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification.Semantic proximity Read ↗

Cardiac Transplantation Using Hearts With Transient Dysfunction: Role of Takotsubo-Like Phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.